Patents by Inventor Hesham H.A. Salman

Hesham H.A. Salman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CYCLOSPORINE A TOPICAL COMPOSITIONS
    Publication number: 20190022174
    Abstract: The present invention relates to topical pharmaceutical microemulsions of cyclosporine Acomprising a half (C-C 4) alkyl esters of poly (methyl vinyl ether-co-maleic anhydride) (PVM/MA) copolymers. The invention also relates to a process for the preparation of said compositions and to their use in the prevention and/or treatment of several diseases, particularly psoriasis and atopic dermatitis.
    Type: Application
    Filed: January 3, 2017
    Publication date: January 24, 2019
    Applicants: SPHERIUM BIOMED, S.L., Bionanoplus, S.L.
    Inventors: Hesham H.A. SALMAN, Irene ESPARZA CATALAN, Benjamin SANTOS LOBO, Nuria LLUCH
  • Nanoparticles comprising a vegetable hydrophobic protein and a water miscible non-volatile organic solvent and uses thereof
    Patent number: 9974753
    Abstract: The present invention relates to nanoparticles for encapsulating compounds, the preparation and uses thereof, said nanoparticles being based on a vegetable hydrophobic protein, particularly zein, and a water miscible non-volatile organic solvent, particularly propylene glycol. Said nanoparticles can encapsulate or incorporate a product of interest for use in the agricultural, cosmetic, food or pharmaceutical fields.
    Type: Grant
    Filed: February 12, 2013
    Date of Patent: May 22, 2018
    Assignee: BIONANOPLUS, S.L.
    Inventors: Hesham H. A. Salman, Izaskun Goñi Azcárate, Irene Esparza Catalán
  • Nanoparticles comprising a cyclodextrin and a biologically active molecule and uses thereof
    Patent number: 9522197
    Abstract: The invention relates to nanoparticles comprising a biodegradable polymer, a cyclodextrin or a derivative thereof, and a biologically active molecule. Said nanoparticles can associate large amounts of biologically active molecules, especially of a hydrophobic nature, and release the biologically active molecule providing sustained and constant plasma levels thereof when they are administered orally or through any other mucosa of the organism.
    Type: Grant
    Filed: April 18, 2008
    Date of Patent: December 20, 2016
    Assignee: INNOUP FARMA, S.L.
    Inventors: Maite Agüeros Bazo, Hesham H. A. Salman, Juan Manuel Irache Garreta, Miguel Angel Campanero Martínez
  • Nanoparticles comprising esters of poly (methyl vinyl ether-co-maleic anhydride) and uses thereof
    Patent number: 9351940
    Abstract: The present invention relates to nanoparticles for encapsulating compounds, the preparation and uses thereof, said nanoparticles being based on half (C1-C4) alkyl esters of poly (methyl vinyl ether-co-maleic anhydride) (PVM/MA) copolymers. Said nanoparticles can encapsulate or incorporate a product of interest for use in the agricultural, cosmetic, food or pharmaceutical fields.
    Type: Grant
    Filed: April 16, 2012
    Date of Patent: May 31, 2016
    Assignee: BIONANOPLUS, S.L.
    Inventors: Hesham H. A. Salman, Izaskun Goñi Azcarate
  • NANOPARTICLES COMPRISING A VEGETABLE HYDROPHOBIC PROTEIN AND A WATER MISCIBLE NON-VOLATILE ORGANIC SOLVENT AND USES THEREOF
    Publication number: 20150004102
    Abstract: The present invention relates to nanoparticles for encapsulating compounds, the preparation and uses thereof, said nanoparticles being based on a vegetable hydrophobic protein, particularly zein, and a water miscible non-volatile organic solvent, particularly propylene glycol. Said nanoparticles can encapsulate or incorporate a product of interest for use in the agricultural, cosmetic, food or pharmaceutical fields.
    Type: Application
    Filed: February 12, 2013
    Publication date: January 1, 2015
    Applicant: BIONANOPLUS, S.L.
    Inventors: Hesham H.A. Salman, Izaskun Goñi Azcárate, Irene Esparza Catalán
  • Immune response stimulating composition comprising nanoparticles based on a methyl vinyl ether-maleic acid copolymer
    Patent number: 8895067
    Abstract: The composition for stimulating an immune response in a subject comprises methyl vinyl ether and maleic anhydride copolymer-based nanoparticles. Said nanoparticles may further contain an allergen or an antigen and/or an immunostimulating agent, which may be contained inside said nanoparticles and/or at least partially coating the surface of said nanoparticles, and optionally a cross-linking agent. The immune response stimulating composition is useful as an adjuvant in immunotherapy and vaccines.
    Type: Grant
    Filed: April 28, 2005
    Date of Patent: November 25, 2014
    Assignee: Universidad de Navarra
    Inventors: Juan Manuel Irache Garreta, Carlos Gamazo De La Rasilla, Maria Luisa Sanz Larruga, Marta Ferrer Puga, Beatriz San Román Aberasturi, Hesham H. A. Salman, Sara Gómez Martinez, Javier Ochoa Rep{dot over (a)}raz
  • NANOPARTICLES COMPRISING ESTERS OF POLY (METHYL VINYL ETHER-CO-MALEIC ANHYDRIDE) AND USES THEREOF
    Publication number: 20140161892
    Abstract: The present invention relates to nanoparticles for encapsulating compounds, the preparation and uses thereof, said nanoparticles being based on half (C1-C4) alkyl esters of poly (methyl vinyl ether-co-maleic anhydride) (PVM/MA) copolymers. Said nanoparticles can encapsulate or incorporate a product of interest for use in the agricultural, cosmetic, food or pharmaceutical fields.
    Type: Application
    Filed: April 16, 2012
    Publication date: June 12, 2014
    Applicant: BIONANOPLUS, S.L.
    Inventors: Hesham H.A. Salman, Izaskun Goni Azcarate
  • NANOPARTICLES COMPRISING A CYCLODEXTRIN AND A BIOLOGICALLY ACTIVE MOLECULE AND USES THEREOF
    Publication number: 20100136129
    Abstract: The invention relates to nanoparticles comprising a biodegradable polymer, a cyclodextrin or a derivative thereof, and a biologically active molecule. Said nanoparticles can associate large amounts of biologically active molecules, especially of a hydrophobic nature, and release the biologically active molecule providing sustained and constant plasma levels thereof when they are administered orally or through any other mucosa of the organism.
    Type: Application
    Filed: April 18, 2008
    Publication date: June 3, 2010
    Applicant: INSTITUTO CIENTÍFICO Y TECNOLÓGICO DE NAVARRA, S.A
    Inventors: Maite Agüeros Bazo, Hesham H.A. Salman, Juan Manuel Irache Garreta, Miguel Angel Campanero Martínez